Ligand ID: 0U9 Drugbank ID: DB01128(Bicalutamide) Indication:For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 1uk4 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | TYR A 54LEU A 57THR A 25GLU A 47THR A 45 | 1.42A | 21.46 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 1wnc | E2 GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU A 930ALA B 926THR B 923ALA A 926THR A 923 | 1.48A | 13.79 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 1zv8 | E2 GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU K 30ALA G 26THR G 23ALA K 26THR K 23 | 1.36A | 7.46 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 2beq | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU C 930ALA A 926THR A 923ALA C 926THR C 923 | 1.35A | 5.92 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 2qc2 | 3C-LIKE PROTEINASE (-) | 5 / 12 | TYR A 54LEU A 57THR A 24GLU A 47THR A 45 | 1.54A | 21.46 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3d0g | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU A 503ARG A 460THR A 449GLU A 457THR A 453 | 1.42A | 23.36 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3ea7 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | TYR A 54LEU A 57THR A 25GLU A 47THR A 45 | 1.50A | 21.68 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3i6k | HLA, A-2MEMBRANEGLYCOPROTEIN PEPTIDE (Homosapiens;SARS-COVTJF) | 5 / 12 | LEU A 160ARG A 157ALA C 2GLU A 154ALA A 158 | 1.47A | 23.15 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | TYR A 54LEU A 57THR A 25GLU A 47THR A 45 | 1.59A | 21.46 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | TYR B 54LEU B 57THR B 25GLU B 47THR B 45 | 1.44A | 21.68 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3sci | ACE2 (Homosapiens) | 5 / 12 | LEU A 503ARG A 460THR A 449GLU A 457THR A 453 | 1.44A | 22.52 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 3scl | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU A 503ARG A 460THR A 449GLU A 457THR A 453 | 1.50A | 22.20 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 4ovz | PAPAIN-LIKEPROTEINASE (SARS-COVUrbani) | 5 / 12 | PHE A 305ARG A 167ALA A 120GLU A 168THR A 169 | 1.55A | 21.48 | NoneDMS B 906 (-3.4A)NoneDMS A 903 (-3.6A)None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 5x4s | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | PHE A 89ALA A 237THR A 247ALA A 250THR A 71 | 1.60A | 19.08 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | TYR C 622LEU C 615THR C 604ALA C 609THR C 608 | 1.61A | 16.25 | NoneNoneNAG C1301 (-3.7A)NoneNone | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 5zvm | PAN-COV INHIBITORYPEPTIDE EK1SPIKE GLYCOPROTEIN (SARSr-CoV;syntheticconstruct) | 5 / 12 | LEU c 25ALA A 926THR A 925GLU A 918THR A 921 | 1.56A | 8.44 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 5zvm | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU C 930ALA B 926THR B 923ALA C 926THR C 923 | 1.33A | 12.41 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU A1016PHE A 870VAL A 767ALA A 858THR A 856 | 1.49A | 16.36 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | PHE B 89ALA B 237THR B 247ALA B 250THR B 71 | 1.56A | 17.05 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | LEU B1016PHE B 870VAL B 767ALA B 858THR B 856 | 1.52A | 16.67 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | LEU A 130ALA A 108GLU A 136ALA A 134THR A 137 | 1.24A | 20.22 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6lxt | SPIKE PROTEIN S2 (SARS-CoV-2) | 5 / 12 | LEU B 948ALA A 944THR A 941ALA B 944THR B 941 | 1.39A | 15.03 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6m18 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | LEU C 244PHE C 327VAL C 324ALA C 406THR C 408 | 1.42A | 21.69 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6m1d | ACE2 (Homosapiens) | 5 / 12 | LEU B 503ARG B 460THR B 449GLU B 457THR B 453 | 1.53A | 21.22 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE A 67LEU A 160TRP A 109ALA A 174THR A 58 | 1.52A | 17.95 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 674VAL A 667ARG A 457ALA A 558THR A 556 | 1.43A | 19.77 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6m71 | NSP8 (SARS-CoV-2) | 5 / 12 | TYR B 138LEU B 169VAL B 186ALA B 188THR B 146 | 1.79A | 19.32 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 530LEU A 527VAL A 373ARG A 654ALA A 376 | 1.76A | 19.77 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6nus | NSP12NSP8 (SARSr-CoV) | 5 / 12 | VAL A 398ARG B 190ALA A 382ALA B 125THR B 124 | 1.50A | 20.08 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | PHE A 802TYR C 707VAL C 705ALA A 893THR A 887 | 1.47A | 16.90 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6vw1 | ACE2 (Homosapiens) | 5 / 12 | LEU B 503ARG B 460THR B 449GLU B 457THR B 453 | 1.46A | 22.03 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | PHE B 802TYR A 707VAL A 705ALA B 893THR B 887 | 1.52A | 15.85 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | PHE C 802TYR B 707VAL B 705ALA C 893THR C 887 | 1.49A | 15.85 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | LEU L 135PHE L 118VAL H 181ALA H 137THR H 135 | 1.74A | 18.50 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | PHE L 139LEU L 135VAL H 181ALA H 137THR H 135 | 1.71A | 18.50 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | TYR B 56LEU B 80ALA B 131GLU B 67ALA B 68 | 1.78A | 20.83 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | TYR C 264ARG C 166ALA C 114GLU C 167THR C 168 | 1.40A | 20.83 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | TYR A 56VAL A 11ALA A 68THR A 74ALA A 131 | 1.71A | 20.83 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92LEU A 56VAL A 53ALA B 150ALA B 110 | 1.70A | 16.18 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | LEU B 73VAL B 70ALA B 95ALA B 81THR B 84 | 1.69A | 23.29 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | LEU A 73VAL A 70ALA A 95ALA A 81THR A 84 | 1.68A | 23.29 | NoneEDO A 408 (-4.0A)NoneNoneNone | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 56VAL C 53ALA D 150ALA D 110 | 1.69A | 16.18 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92LEU A 56VAL A 53ALA B 150ALA B 110 | 1.71A | 16.18 | NoneNoneEDO B 302 ( 4.8A)EDO B 302 (-3.7A)None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | TYR A 56VAL A 11ALA A 68THR A 74ALA A 131 | 1.73A | 19.96 | None CL A 506 (-3.7A)NoneNoneNone | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 6 / 12 | TYR A 56LEU A 80PHE A 79ALA A 131GLU A 67ALA A 68 | 1.76A | 19.96 | NoneNoneNoneNone CL A 506 (-3.5A)None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 56VAL C 53ALA D 150ALA D 110 | 1.74A | 14.77 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE B 92LEU A 56VAL A 53ALA B 150ALA B 110 | 1.75A | 14.77 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | LEU D 128VAL D 130THR D 141ALA D 152THR D 148 | 1.78A | 14.77 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | TYR A 54LEU A 57THR A 24GLU A 47THR A 45 | 1.71A | 21.89 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | TYR A 54LEU A 57THR A 25GLU A 47THR A 45 | 1.76A | 21.89 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7btf | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 56VAL C 53ALA D 150ALA D 110 | 1.52A | 19.32 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 240PHE A 45ARG A 733ALA A 125THR A 206 | 1.79A | 19.77 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 530LEU A 527ALA A 376THR A 538GLU A 658 | 1.64A | 19.69 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | VAL A 398ARG B 190ALA A 382ALA B 125THR B 124 | 1.70A | 19.69 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 56VAL C 53ALA D 150ALA D 110 | 1.60A | 18.34 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv1 | NSP8 (SARS-CoV-2) | 5 / 12 | TYR B 138LEU B 169VAL B 186ALA B 188THR B 146 | 1.78A | 18.34 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 674VAL A 667ARG A 457ALA A 558THR A 556 | 1.49A | 19.69 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 748PHE A 753ALA A 699THR A 701ALA A 706 | 1.79A | 19.69 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv2 | NSP8 (SARS-CoV-2) | 5 / 12 | TYR B 138LEU B 169VAL B 186ALA B 188THR B 146 | 1.76A | 18.34 | None |